News & Updates
Filter by Specialty:
Novel biomarkers predict immunotherapy response, side effects in HCC
A team of Singapore-based researchers has identified two blood biomarkers that not only predict clinical response to immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) patients but also the incidence of side effects from the same treatment.
Novel biomarkers predict immunotherapy response, side effects in HCC
02 Jun 2022
Multivitamins help improve colorectal cancer survival
Patients who take multivitamin supplements at a moderate dose following their diagnosis of nonmetastatic colorectal cancer (CRC) appear to have a lower mortality, reports a recent study.
Multivitamins help improve colorectal cancer survival
02 Jun 2022
INCREASE OLE data reflect long-term benefit of inhaled treprostinil for PH-ILD
Findings from the open-label extension (OLE) phase of the INCREASE study boost the efficacy and safety of inhaled treprostinil for pulmonary hypertension due to interstitial lung disease (PH-ILD).
INCREASE OLE data reflect long-term benefit of inhaled treprostinil for PH-ILD
31 May 2022
MS patients on certain DMTs may have limited protection from COVID-19 vax
The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.